While it is clear that the impaired hematopoietic differentiation of trisomy 21 serves as the basis for the selective advantage of clones with GATA1 mutations, it is unknown under which mechanisms the additional mutations promote the development of ML-DS. The gene discussed is GATA1; the disease is Dravet syndrome.